Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

72.73 -1.39 (-1.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,160,831
Open 74.42
Bid (Size) 72.75 (100)
Ask (Size) 74.00 (100)
Prev. Close 74.12
Today's Range 72.08 - 75.13
52wk Range 54.11 - 89.98
Shares Outstanding 384,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Mid-Cap Stock to Target This Week and 2 We Find Risky
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
DEXCOM INC (NASDAQ:DXCM) Screens as a Strong Growth Stock with Favorable Technical Setup ↗
Via Chartmill

Performance

YTD
+9.3%
+9.3%
1 Month
-2.0%
-2.0%
3 Month
+18.2%
+18.2%
6 Month
+4.3%
+4.3%
1 Year
-14.2%
-14.2%

More News

Read More
News headline image
Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
DexCom (NASDAQ:DXCM): An Affordable Growth Pick With Strong Momentum and Financial Health ↗
Via Chartmill
News headline image
Patient Monitoring Stocks Q1 Results: Benchmarking DexCom (NASDAQ:DXCM)
Via StockStory
Topics Artificial Intelligence
DexCom Inc (NASDAQ:DXCM) Passes Rigorous Quality Screen with Strong Profitability and Growth Metrics ↗
Via Chartmill
News headline image
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down
Via StockStory
News headline image
3 Nasdaq 100 Stocks with Promising Prospects
Via StockStory
News headline image
Dexcom Further Advances Vision of Glucose Biosensing for All
From DexCom, Inc.
Via Business Wire
News headline image
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16? ↗
Via The Motley Fool
News headline image
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend ↗
Via MarketBeat
Topics ETFs
News headline image
3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗
Via MarketBeat
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Find Risky
Via StockStory
News headline image
3 Reasons Investors Love DexCom (DXCM)
Via StockStory
Topics Stocks
News headline image
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
Via StockStory
News headline image
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
From DexCom, Inc.
Via Business Wire
News headline image
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
From Dexcom
Via Business Wire
News headline image
2 Growth Stocks to Buy and Hold for a Decade ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
From Dexcom
Via Business Wire
News headline image
Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
From DexCom, Inc.
Via Business Wire
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
From DexCom, Inc.
Via Business Wire
News headline image
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day ↗
Via MarketBeat
What's going on in today's session: S&P500 movers ↗
Via Chartmill

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 72.73
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 07/15/26 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 27.99B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 28B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.